Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/16/2026 | 13,601 | 0.2% | 30,000 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 12,611 | 0.2% | 32,200 | 9/30/2025 |
| 2025 Q2 | 7/23/2025 | 14,380 | 0.3% | 32,300 | 6/30/2025 |
| 2025 Q1 | 5/1/2025 | 15,805 | 0.3% | 32,600 | 3/31/2025 |
| 2024 Q4 | 1/29/2025 | 13,168 | 0.2% | 32,700 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 15,906 | 0.3% | 34,200 | 9/30/2024 |
| 2024 Q2 | 7/24/2024 | 16,452 | 0.3% | 35,100 | 6/30/2024 |
| 2024 Q1 | 4/23/2024 | 14,756 | 0.3% | 35,300 | 3/31/2024 |
| 2023 Q4 | 1/29/2024 | 14,689 | 0.3% | 36,100 | 12/31/2023 |
| 2023 Q3 | 10/17/2023 | 12,658 | 0.3% | 36,400 | 9/30/2023 |
| 2023 Q2 | 7/18/2023 | 11,261 | 0.2% | 32,000 | 6/30/2023 |
| 2023 Q1 | 4/19/2023 | 9,295 | 0.2% | 29,500 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 8,490 | 0.2% | 29,400 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 8,744 | 0.3% | 30,200 | 9/30/2022 |
| 2022 Q2 | 7/20/2022 | 8,660 | 0.2% | 29,900 | 6/30/2022 |
| 2022 Q1 | 4/22/2022 | 8,473 | 0.2% | 29,700 | 3/31/2022 |
| 2021 Q4 | 1/14/2022 | 6,457 | 0.1% | 29,400 | 12/31/2021 |
| 2021 Q3 | 10/12/2021 | 5,351 | 0.1% | 29,500 | 9/30/2021 |
| 2021 Q2 | 7/16/2021 | 5,948 | 0.1% | 29,500 | 6/30/2021 |
| 2021 Q1 | 4/14/2021 | 6,340 | 0.2% | 29,500 | 3/31/2021 |
| 2020 Q4 | 1/11/2021 | 6,499 | 0.2% | 27,500 | 12/31/2020 |
| 2020 Q3 | 10/19/2020 | 3,592 | 0.2% | 13,200 | 9/30/2020 |
| 2020 Q2 | 7/13/2020 | 3,222 | 0.2% | 11,100 | 6/30/2020 |
| 2020 Q1 | 4/13/2020 | 2,594 | 0.2% | 10,900 | 3/31/2020 |
| 2019 Q4 | 1/17/2020 | 2,671 | 0.1% | 12,200 | 12/31/2019 |
| 2014 Q2 | 7/30/2014 | 1,752 | 0.1% | 18,500 | 6/30/2014 |
| 2014 Q1 | 4/29/2014 | 1,322 | 0.1% | 18,700 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 1,397 | 0.1% | 18,800 | 12/31/2013 |